NASDAQ: APLT
Applied Therapeutics Inc Stock Ownership - Who owns Applied Therapeutics?

Insider buying vs selling

Have Applied Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Constantine ChinoporosChief Operating Officer and Chief Business Officer2025-03-04447$0.44
$196.68Sell
Leslie D. FuntleyderInterim Chief Executive Officer and Chief Financial Officer2025-03-0414,502$0.44
$6.38kSell
Riccardo PerfettiChief Medical Officer2025-03-0410,366$0.44
$4.56kSell
Constantine ChinoporosChief Operating Officer and Chief Business Officer2025-02-0628,117$0.61
$17.15kSell
Leslie D. FuntleyderInterim Chief Executive Officer and Chief Financial Officer2025-02-0622,950$0.61
$14.00kSell
Riccardo PerfettiChief Medical Officer2025-02-0686,078$0.61
$52.51kSell

1 of 1

APLT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APLT insiders and whales buy or sell their stock.

APLT Shareholders

What type of owners hold Applied Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc12.97%18,683,990$7.87MInstitution
Vestal Point Capital LP7.99%11,500,000$4.84MInstitution
Propel Bio Management LLC7.84%11,285,420$4.75MInstitution
Knoll Capital Management LLC5.42%7,799,687$3.28MInstitution
Shoshana Shendelman4.20%6,049,953$2.55MInsider
Blackrock Inc3.62%5,219,686$2.20MInstitution
Vanguard Group Inc3.29%4,734,013$1.99MInstitution
Simplify Asset Management Inc3.12%4,487,505$1.89MInstitution
Pathstone Holdings LLC1.84%2,643,540$1.11MInstitution
Tang Capital Management LLC1.69%2,428,169$1.02MInstitution

1 of 3

APLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APLT61.09%8.42%Net Selling
MNOV10.54%89.10%
GANX10.54%3.63%
CELU2.01%97.99%Net Buying
ARTV54.13%45.87%Net SellingNet Selling

Applied Therapeutics Stock Ownership FAQ

Who owns Applied Therapeutics?

Applied Therapeutics (NASDAQ: APLT) is owned by 61.09% institutional shareholders, 8.42% Applied Therapeutics insiders, and 30.49% retail investors. Shoshana Shendelman is the largest individual Applied Therapeutics shareholder, owning 6.05M shares representing 4.20% of the company. Shoshana Shendelman's Applied Therapeutics shares are currently valued at $2.55M.

If you're new to stock investing, here's how to buy Applied Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.